Skip to content
drillr.ai
Sign up

NIKI

Niki BioSolutions, Inc.

NASDAQ · Healthcare · Biotechnology · US

$6.20
−4.76%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue———431.4K1.3M
Cost of Revenue——255.0K420.8K1.2M
Gross Profit——(255.0K)10.6K80.1K
Operating Expenses
R&D Expense68.4K352.9K1.9M5.2M9.2M
SG&A Expense2.1M1.6M1.5M4.4M8.0M
General & Admin Expense1.5M1.6M—4.4M7.9M
Selling & Marketing Expense———49.0K98.1K
Other Expenses(890.2K)(170.8K)128.0K999.0K69.0K
Total Operating Expenses1.3M1.8M3.5M10.6M17.3M
Cost and Expenses1.3M1.8M3.8M11.0M18.8M
Operating Income (EBIT)(402.8K)(1.8M)(3.8M)(10.6M)(17.5M)
Non-Operating
Interest Income————146.6K
Interest Expense73.5K95.7K146.9K121.1K—
Net Interest Income(73.5K)(95.7K)(147.0K)(121.0K)146.6K
Other Non-Op Income/Expense(1.7M)441.1K(361.0K)6.3M6.0M
Non-Operating Income (excl Interest)1.1M—214.3K—(6.0M)
EBT (Pre-Tax Income)(2.1M)(1.4M)(4.2M)(4.3M)(11.5M)
Income Tax Expense—————
Bottom Line
Net Income(2.3M)(1.4M)(4.3M)(2.8M)(9.8M)
Earnings from Cont. Ops(2.1M)(1.4M)(4.2M)(4.3M)(11.5M)
Earnings from Discont. Ops—————
Bottom Line Net Income(2.3M)(1.4M)(4.3M)(2.8M)(9.8M)
Per Share
Basic EPS($33.50)($19.00)($78.00)($62.00)($275.00)
Diluted EPS($33.50)($19.00)($78.00)($62.00)($275.00)
Revenue Per Share$0.00$0.00$0.00$9.54$36.31
Shares
Basic Shares Outstanding7351873518545304521035690
Diluted Shares Outstanding7351873518545304521035690
Profitability Metrics
EBITDA(1.5M)(1.8M)(3.8M)(9.5M)(10.3M)
D&A——255.0K1.1M1.2M
EBIT(1.5M)(1.8M)(4.0M)(10.6M)(11.5M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025